About
Contact & Profiles
Research Areas
- PI3K/AKT/mTOR signaling in cancer
- Chronic Lymphocytic Leukemia Research
- Metabolism, Diabetes, and Cancer
Alexandria University
2023
Targeting toll-like receptors (TLRs), via TLR agonists, has been implicated in the regulation of immunometabolism. B-chronic lymphocytic leukemia (B-CLL) represents a suitable model for B-cell derived malignancies with shifted metabolic adaptations. Several signaling pathways have found to be critical reprogramming CLL, including mechanistic target rapamycin- hypoxia inducible factor-1α (mTOR- HIF-1α) pathway, main regulator glycolysis. Here, we investigated effect TLR7/8 agonist...
10.1007/s12288-023-01649-y
article
EN
cc-by
Indian Journal of Hematology and Blood Transfusion
2023-04-07
Coming Soon ...